Musculoskeletal repair — tendons, ligaments, muscle, and bone — is one of the most active areas in research peptide work. This article surveys the peptides most often studied for these tissues, with a focus on their distinct mechanisms.
BPC-157 and General Tissue Repair
BPC-157 is a synthetic pentadecapeptide derived from a sequence found in human gastric juice. It has become one of the most studied peptides in animal models of tendon, ligament, and muscle injury.
Research has documented effects on angiogenesis, collagen organization, and growth factor expression. The peptide appears to influence the nitric oxide system bidirectionally, and this modulation may contribute to its broad activity across tissue types.
Most BPC-157 data come from rodent models, and the translation to larger animals — let alone humans — remains an open question that the literature continues to examine.
TB-500 and Cellular Migration
TB-500 is a synthetic fragment of thymosin beta-4, a naturally occurring protein involved in cell migration and actin regulation. Research interest has centered on its role in helping cells move into damaged tissue, an early step in wound healing.
Studies have explored its effects in cardiac, dermal, and musculoskeletal injury models. The mechanism — promoting cellular movement and reducing inflammation — is distinct from but complementary to BPC-157's pathway, which is part of why the two are sometimes paired in research.
Like BPC-157, most published TB-500 data come from animal studies.
GHK-Cu and Extracellular Matrix Remodeling
GHK-Cu is a copper-binding tripeptide that has been studied for decades. Research has documented effects on collagen and elastin synthesis, antioxidant activity, and gene expression patterns related to tissue remodeling.
Most early GHK-Cu work focused on skin, but research has also examined bone and connective tissue applications. Its copper-binding capacity is central to its activity, since copper is a cofactor for several enzymes involved in matrix maturation.
The peptide is among the most thoroughly characterized in the research-peptide space, with a substantial published literature spanning multiple tissue types.
Growth Hormone Secretagogues
Peptides that act on the growth hormone axis — including ipamorelin, CJC-1295, and tesamorelin — are studied in musculoskeletal contexts because growth hormone and IGF-1 are central to muscle and bone biology. These peptides act on different points in the axis and have different pharmacokinetic profiles.
Research interest in this category has been steady, particularly around questions of whether targeted, pulsatile pathway activation produces different outcomes than direct hormone administration.
Musculoskeletal peptide research continues to expand, and the relative roles of these compounds — alone or in combination — remain active questions in the literature. All peptides discussed are intended for research use only and are not for human consumption.